Logo image
Sign in
Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency
Letter/Communication   Peer reviewed

Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Holly A.F. Stessman, Aatif Mansoor, Michael A. Linden, Brian Van Ness and Linda B. Baughn
Leukemia and Lymphoma, Vol.55(1), pp.220-222
55
01/01/2014
PMID: 23734619

Abstract

Hematology Oncology Cancer Research

Metrics

4 Record Views

Details